000 01189 a2200349 4500
005 20250513115221.0
264 0 _c19970623
008 199706s 0 0 eng d
022 _a0147-0272
024 7 _a10.1016/s0147-0272(97)80002-5
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGreven, K M
245 0 0 _aEndometrial cancer.
_h[electronic resource]
260 _bCurrent problems in cancer
_c
300 _a65-127 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aCombined Modality Therapy
650 0 4 _aEndometrial Neoplasms
_xdiagnosis
650 0 4 _aEstrogen Replacement Therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aPrevalence
650 0 4 _aProgestins
_xtherapeutic use
650 0 4 _aPrognosis
650 0 4 _aRadiotherapy, Adjuvant
650 0 4 _aUnited States
_xepidemiology
700 1 _aCorn, B W
773 0 _tCurrent problems in cancer
_gvol. 21
_gno. 2
_gp. 65-127
856 4 0 _uhttps://doi.org/10.1016/s0147-0272(97)80002-5
_zAvailable from publisher's website
999 _c9110328
_d9110328